Inventor · disambiguated record
Richard D. Wilson
Also filed as: WILSON RICHARD · WILSON RICHARD D
14 granted patents·3 pending applications·66 citations·filing 2003–2020
92Inventor score
Files withTHERAVANCE RESPIRATORY CO LLC9THERAVANCE INC4HUGHES ADAM1MAMMEN MATHAI1WAUGH DAVID JOHN JAMES1
Top patents by PatentIndex Score
17 records- 0191US9682957B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Jun 20, 2017·5 cites·2 claims
- 0291US9572802B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2016·Granted Feb 21, 2017·5 cites·30 claims
- 0391US8138345B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityHUGHES ADAM·Filed 2010·Granted Mar 20, 2012·13 cites·3 claims
- 0490US9975875B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted May 22, 2018·4 cites·3 claims
- 0590US7880010B2Crystalline forms of a dimethylphenyl compoundTHERAVANCE INC·Filed 2007·Granted Feb 1, 2011·17 cites·13 claims
- 0689US9771350B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2017·Granted Sep 26, 2017·4 cites·2 claims
- 0781US10138220B1Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Nov 27, 2018·1 cites·26 claims
- 0877US7285564B2Substituted 4-amino-1-(pyridylmethyl)piperidine and related compoundsTHERAVANCE INC·Filed 2003·Granted Oct 23, 2007·10 cites·36 claims
- 0976US2021024493A1Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist ActivityTHERAVANCE RESPIRATORY CO LLC·Filed 2020·Application pending·0 cites
- 1075US7368463B2Substituted 4-amino-1-benzylpiperidine compoundsTHERAVANCE INC·Filed 2004·Granted May 6, 2008·7 cites·32 claims
- 1174US10836744B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2020·Granted Nov 17, 2020·0 cites·22 claims
- 1274US10590107B2Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2019·Granted Mar 17, 2020·0 cites·26 claims
- 1372US10358433B2Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityTHERAVANCE RESPIRATORY CO LLC·Filed 2018·Granted Jul 23, 2019·0 cites·26 claims
- 1457US8080565B2Substituted 4-amino-benzylpiperidine compoundsMAMMEN MATHAI·Filed 2008·Granted Dec 20, 2011·0 cites·15 claims
- 1547US2005113413A1Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compoundFiled 2004·Application pending·0 cites
- 1644US2011086881A1Crystalline forms of a dimethylphenyl compoundTHERAVANCE INC·Filed 2010·Application pending·0 cites
- 1732US9823256B2CXCR1 as a predictor of response to treatment with epidermal growth factor receptor therapeuticWAUGH DAVID JOHN JAMES·Filed 2012·Granted Nov 21, 2017·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Richard D. Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →